Skip to main content
SpringerLink
Log in

Prescribing errors involving medication dosage forms

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

CONTEXT: Prescribing errors involving medication dose formulations have been reported to occur frequently in hospitals. No systematic evaluations of the characteristics of errors related to medication dosage formulation have been performed.

OBJECTIVE: To quantify the characteristics, frequency, and potential adverse patient effects of prescribing errors involving medication dosage forms.

DESIGN: Evaluation of all detected medication prescribing errors involving or related to medication dosage forms in a 631-bed tertiary care teaching hospital.

MAIN OUTCOME MEASURES: Type, frequency, and potential for adverse effects of prescribing errors involving or related to medication dosage forms.

RESULTS: A total of 1,115 clinically significant prescribing errors involving medication dosage forms were detected during the 60-month study period. The annual number of detected errors increased throughout the study period. Detailed analysis of the 402 errors detected during the last 16 months of the study demonstrated the most common errors to be: failure to specify controlled release formulation (total of 280 cases; 69.7%) both when prescribing using the brand name (148 cases; 36.8%) and when prescribing using the generic name (132 cases; 32.8%); and prescribing controlled delivery formulations to be administered per tube (48 cases; 11.9%). The potential for adverse patient outcome was rated as potentially “fatal or severe” in 3 cases (0.7%), and “serious” in 49 cases (12.2%). Errors most commonly involved cardiovascular agents (208 cases; 51.7%).

CONCLUSIONS: Hospitalized patients are at risk for adverse outcomes due to prescribing errors related to inappropriate use of medication dosage forms. This information should be considered in the development of strategies to prevent adverse patient outcomes resulting from such errors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA. 1995;274:35–43.

    Article  PubMed  CAS  Google Scholar 

  2. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA. 1995;274:29–34.

    Article  PubMed  CAS  Google Scholar 

  3. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285:2114–20.

    Article  PubMed  CAS  Google Scholar 

  4. Lesar TS, Briceland LL, Stein DL. Factors related to errors in medication prescribing. JAMA. 1997;277:312–7.

    Article  PubMed  CAS  Google Scholar 

  5. Lesar TS. Errors in the use of medication dosage equations. Arch Pediatr Adolesc Med. 1998;152:340–4.

    PubMed  CAS  Google Scholar 

  6. Purdy B, Raymond A, Lesar T. Antiretroviral prescribing errors in a teaching hospital. Ann Pharmacother. 2000;34:833–8.

    Article  PubMed  CAS  Google Scholar 

  7. Goldberg RJ, Kaniecki DL. Selection of oral controlled release drugs: a critical decision for the physician. S Med J. 1993;86:208–14.

    Google Scholar 

  8. Casteneda-Hernandez G, Caille G, du Souich P. Influence of drug formulation on drug concentration-effect relationships. Clin Pharmacokinet. 1994;26:135–43.

    Article  Google Scholar 

  9. Lesar TS. Medication errors involving medication dosage formulations. Medscape Pharmacist 2001 Available at: http://www.medscape.com/Medscape/pharmacists/journal/2001/v02.n04/mph7675.lesa/mph7675.lesa-01.html. Accessed September, 2001.

  10. Lesar TS. Common prescribing errors. Ann Intern Med. 1992;117:537–8.

    PubMed  CAS  Google Scholar 

  11. Grunewald RA, Mack CJ. Medical errors. Different formulations of drugs often look confusingly similar. BMJ. 2001;322:1423.

    PubMed  CAS  Google Scholar 

  12. Mack CJ, Kuc S, Grunewald RA. Errors in prescribing, dispensing and administration of carbamazepine: a case report and analysis. Pharm J. 2000;265:756–9.

    Google Scholar 

  13. Cohen M, Davis N. Drug name suffixes can cause confusion. Am Pharm. 1992;32:301–2.

    Google Scholar 

  14. Smetzer JL, Cohen M. Lesson from the Denver medication error/criminal negligence case: look beyond blaming individuals. Hosp Pharm. 1998;33:640–57.

    Google Scholar 

  15. Cohen M. Many wrongly believe long-acting parenteral penicillins are for intravenous injection. ISMP Medication Safety Alert! 1999;4:1 Available at: http://www.ismp.org/MSArtices/ParenPCN.html. Accessed September, 2001.

    CAS  Google Scholar 

  16. Pharmacopeia USP. Summary of the 1999 Information submitted to MedMARx. Available at: www.usp.org/medmarx. Accessed September, 2001.

  17. Cohen M. Extra caution needed with U-500 insulin. ISMP Medication Safety Alert! January 29, 1997. Available at: www.ismp.org/mSArticles/U500ins.html. Accessed September, 2001.

  18. Cohen M. Inadequate treatment of syphilis with BICILLIN C-R. ISMP Medication Safety Alert! September 22, 1999. Available at: http://www.ismp.org/MSArticles/Calendar/Sept99.html. Accessed September, 2001.

  19. Cohen M. New strategies required to prevent esmolol related accidental deaths. ISMP Medication Safety Alert! September 25, 1996. Available at: www.ismp.org/mSArticles/esmolol.html. Accessed September, 2001.

  20. Vissers RJ, Purssell R. Iatrogenic magnesium overdose: two case reports. J Emerg Med. 1996;14:187–91.

    Article  PubMed  CAS  Google Scholar 

  21. Hoffman RS, Smilkstein MJ, Rubenstein F. An ‘amp’ by any other name: the hazards of intravenous magnesium dosing. JAMA. 1989;261:557.

    Article  PubMed  CAS  Google Scholar 

  22. Cohen M. Willingness of staff to give oral meds IV is disconcerting. ISMP Medication Safety Alert! May 20, 1998. Available at: www.ismp.org/mSArticles/Oral2.html. Accessed September, 2001.

  23. Krichbaum DW, Malone PM. Subcutaneous administration of nifedipine. Drug Intell Clin Pharm. 1988;22:891–2.

    PubMed  CAS  Google Scholar 

  24. Cohen M. Another ampho-terrible mix-up. ISMP Medication Safety Alert! July 15, 1998. Available at: http://www.ismp.org/MSAarticles/ampho-terrible.html. Accessed September, 2001.

  25. Cohen M. Medication errors with certain lipid based products. ISMP Medication Safety Alert! August 18, 1998. Available at: http://www.ismp.org/MSAarticles/Ampho-alert.html. Accessed September, 2001.

  26. Cohen M. FDA approval for an amphotericin B labeling supplement. ISMP Medication Safety Alert! Available at http://www.ismp.org/MSAarticles/Calendar/Jan99.html. Accessed September, 2001.

  27. Cohen M. Safety Briefs. (Lipid based Amphotericin B). ISMP Medication Safety Alert! 1998;3(No 8). Available at: www.ismp.org. Accessed December, 2001.

  28. Cohen M. Don’t confuse new liposomal doxorubicin with conventional doxorubicin. ISMP Medication Safety Alert! October 9, 1996. Available at: www.ismp.org/MSArticles/doxorub.html. Accessed September, 2001.

  29. Cohen M. Hazard Alert! Action needed to avert fatal errors from concomitant use of heparin products. ISMP Medication safety Alert! February 21, 2001. Available at: www.ismp.org/MSArticles/heparinalert.html. Accessed September, 2001.

  30. Davis N. How easy it is for an error to get through the system. Hosp Pharm. 1992;27:944.

    Google Scholar 

  31. Proulx SM, Melchiorre HA. New dosage forms lead to confusion. US Pharm 2001;Feb:68–9.

    Google Scholar 

  32. Cohen M. Prevention of adverse events caused by potassium phosphate injection. ISMP Medication Safety Alert! March 13, 1996. Available at: www.ismp.org/MSArticles/96Phosphate.html. Accessed September, 2001.

  33. Cohen M. ISMP Quarterly action agenda: January–March 2000. Procan SR dispensed for ProcanBID. ISMP Medication Safety Alert! April 5, 2000. Available at: http://www.ismp.org/MSArticles/2Q00Action.html. Accessed September, 2001.

  34. Anon. Neurology/psychiatry: potential for mix-ups between the new Depakote ER and the original Depakote tablets. Pharm Lett. 2001;17:2.

  35. Cohen M. Depakote ER—easy to confuse with Depakote (delayed release). ISMP Medication Safety Alert! February 7, 2001. Available at: www.ismp.org. Accessed September, 2001.

  36. Laberge P, Martineau P, Sebajang H, Lalonde G. Verapamil intoxication after substitution of immediate-release for extended-release verapamil. Am J Health Syst Pharm. 2001;58:402–5.

    PubMed  CAS  Google Scholar 

  37. Cohen M. Medication errors with oxycodone products. ISMP Medication Safety Alert! 1998;3(No 8). Available at: www.ismp.org. Accessed September, 2001.

  38. Cohen M. Action may be necessary to prevent confusion between Roxanne’s oral liquid opiate products. ISMP Medication Safety Alert! December 18, 1996. Available at: www.ismp.org/mSArticles/Roxanne.html. Accessed September, 2001.

  39. Cohen M. Ongoing confusion: paregoric and opium tincture. ISMP Medication Safety Alert! June 19, 1996. Available at: www.ismp.org/mSArticles/Oral.html. Accessed September, 2001.

  40. Cohen M. Zydis: a new dosage form can be confused with a drug name. Pharm Today. 2001;7:13.

    Google Scholar 

  41. Anon. What happens when critical information is left open to interpretation? (Neoral Advertisement). New York: Novartis Pharmaceuticals; 1998.

  42. Kearns GL, Leeder JS, Wasserman GS. Acetaminophen overdose with therapeutic intent. J Pediatr. 1998;132:5–8.

    Article  PubMed  CAS  Google Scholar 

  43. Cohen M. Safety Briefs. (liquid acetaminophen). ISMP Medication Safety Alert! 1999;4(No. 12). Available at: www.ismp.org. Accessed September, 2001.

  44. Cohen M. Using oral syringes won’t necessarily protect against inadvertent IV injections of oral liquids. ISMP Medication Safety Alert! August 14, 1996. Available at: www.ismp.org/mSArticles/Oral.html. Accessed September, 2001.

  45. Cohen M. Oral liquid medications may be more vulnerable to errors than previously recognized. ISMP Medication Safety Alert! June 28, 2000. Available at: www.ismp.org/mSArticles/oralliquids.html. Accessed September, 2001.

  46. Lesar TS, Briceland LL, Delcoure K, Crilly Parmalee J, Masta-Gornic V, Pohl H. Medication prescribing errors in a teaching hospital. JAMA. 1990;263:2329–34.

    Article  PubMed  CAS  Google Scholar 

  47. Lesar TS, Lomaestro BM, Pohl H. Medication prescribing errors in a teaching hospital: a nine-year experience. Arch Intern Med. 1997;157:1569–76.

    Article  PubMed  CAS  Google Scholar 

  48. Overhage JM, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities. Am J Health Syst Pharm. 1999;56:2444–50.

    PubMed  CAS  Google Scholar 

  49. Holquist C, Phillips J. How FDA reviews drug names. Drug Topics. 2001;April 2:36.

    Google Scholar 

  50. Phillips J. FDA Efforts at minimizing the risks of preventable adverse drug events. Medscape Pharmacist. July, 2000. Available at: http://www.medscape.com/medscape/pharmacists/journal/2000/v01.n04/mph7174.phil/mph7174.phil-01.html. Accessed September, 2001.

  51. Lesar TS. Recommendations for reducing medication errors. Medscape Pharmacist. 2000. Available at: www.medscape.com/medscape/pharmacist/journal/2000/v01.n04/mph7175.lesa-01.html. Accessed September, 2001.

  52. Cohen M, ed. Medication Errors. Washington, DC: American Pharmaceutical Association; 1999.

    Google Scholar 

  53. Bates DW, Leape LL, Cullen DW, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998;80:1311–6.

    Article  Google Scholar 

  54. Rich D. Ask the Joint Commission. Surveying medication use in 2001. Hosp Pharm 2001;36:444–6

    Google Scholar 

  55. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Albany Medical Center, New Scotland Ave., Mail-code 85 43, 12208, Albany, NY

    Timothy S. Lesar Pharm D

Authors
  1. Timothy S. Lesar Pharm D
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy S. Lesar Pharm D.

Additional information

Received from Albany Medical Center, Albany, NY.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lesar, T.S. Prescribing errors involving medication dosage forms. J GEN INTERN MED 17, 579–587 (2002). https://doi.org/10.1046/j.1525-1497.2002.11056.x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1046/j.1525-1497.2002.11056.x

Key words

Search

Navigation